X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22317) 22317
Newsletter (1449) 1449
Publication (1124) 1124
Book Chapter (191) 191
Book Review (187) 187
Newspaper Article (70) 70
Magazine Article (38) 38
Book / eBook (19) 19
Conference Proceeding (15) 15
Dissertation (12) 12
Web Resource (10) 10
Reference (3) 3
Trade Publication Article (3) 3
Data Set (1) 1
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17874) 17874
female (10548) 10548
thrombocytopenia (10085) 10085
male (9417) 9417
middle aged (6872) 6872
adult (6800) 6800
thrombocytopenia - chemically induced (6356) 6356
index medicus (6153) 6153
aged (5437) 5437
hematology (4713) 4713
oncology (2858) 2858
treatment outcome (2702) 2702
thrombocytopenia - therapy (2693) 2693
thrombocytopenia - etiology (2688) 2688
platelet count (2522) 2522
thrombocytopenia - drug therapy (2310) 2310
adolescent (2162) 2162
heparin - adverse effects (2147) 2147
therapy (1921) 1921
care and treatment (1894) 1894
child (1771) 1771
research (1753) 1753
thrombocytopenia - complications (1692) 1692
risk factors (1661) 1661
animals (1600) 1600
heparin-induced thrombocytopenia (1579) 1579
thrombocytopenia - diagnosis (1560) 1560
retrospective studies (1542) 1542
pregnancy (1453) 1453
anticoagulants - adverse effects (1427) 1427
medicine, general & internal (1398) 1398
aged, 80 and over (1383) 1383
chemotherapy (1381) 1381
antineoplastic combined chemotherapy protocols - therapeutic use (1328) 1328
thrombocytopenia - blood (1324) 1324
purpura (1318) 1318
thrombosis (1278) 1278
diagnosis (1276) 1276
cancer (1238) 1238
heparin (1229) 1229
pediatrics (1220) 1220
management (1200) 1200
blood platelets (1197) 1197
infant, newborn (1184) 1184
anticoagulants - therapeutic use (1175) 1175
thrombocytopenia - immunology (1161) 1161
child, preschool (1153) 1153
platelets (1132) 1132
pharmacology & pharmacy (1118) 1118
drug therapy (1107) 1107
antineoplastic combined chemotherapy protocols - adverse effects (1104) 1104
patients (1100) 1100
neutropenia - chemically induced (1094) 1094
leukopenia - chemically induced (1087) 1087
immune thrombocytopenia (1084) 1084
time factors (1075) 1075
health aspects (1036) 1036
medicine & public health (1017) 1017
peripheral vascular disease (1005) 1005
platelet transfusion (997) 997
infant (996) 996
drug administration schedule (956) 956
antibodies (952) 952
splenectomy (949) 949
anemia (944) 944
surgery (940) 940
anticoagulants (933) 933
medical research (930) 930
analysis (894) 894
young adult (882) 882
children (859) 859
antineoplastic agents - adverse effects (857) 857
prognosis (853) 853
dose-response relationship, drug (829) 829
complications and side effects (805) 805
medicine, experimental (789) 789
immunology (783) 783
follow-up studies (779) 779
prospective studies (752) 752
neutropenia (715) 715
blood transfusion (706) 706
heparin - therapeutic use (698) 698
transplantation (693) 693
molecular-weight heparin (682) 682
antineoplastic agents - therapeutic use (675) 675
abridged index medicus (666) 666
drug therapy, combination (652) 652
blood platelets - immunology (620) 620
toxicity (615) 615
recombinant proteins - therapeutic use (608) 608
reports (603) 603
diagnosis, differential (600) 600
purpura, thrombocytopenic, idiopathic - drug therapy (595) 595
disease (593) 593
neoplasms - drug therapy (582) 582
blood (569) 569
medicine (563) 563
risk (562) 562
cardiac & cardiovascular systems (559) 559
rituximab (554) 554
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21327) 21327
German (768) 768
French (591) 591
Japanese (376) 376
Spanish (216) 216
Chinese (156) 156
Russian (152) 152
Italian (111) 111
Polish (95) 95
Dutch (38) 38
Korean (32) 32
Czech (31) 31
Hungarian (30) 30
Croatian (24) 24
Danish (20) 20
Turkish (19) 19
Portuguese (15) 15
Hebrew (14) 14
Romanian (14) 14
Serbian (14) 14
Swedish (12) 12
Finnish (11) 11
Norwegian (11) 11
Slovak (10) 10
Bulgarian (5) 5
Slovenian (3) 3
Arabic (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Latvian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e737S - e801S
Background: Neonates and children differ from adults in physiology, pharmacologic responses to drugs, epidemiology, and long-term consequences of thrombosis.... 
INFERIOR VENA-CAVA | TISSUE-PLASMINOGEN-ACTIVATOR | ARTERIAL ISCHEMIC-STROKE | RESPIRATORY SYSTEM | CEREBRAL SINOVENOUS THROMBOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | HEPARIN-INDUCED THROMBOCYTOPENIA | SICKLE-CELL-DISEASE | HOMOZYGOUS PROTEIN-C | CRITICAL CARE MEDICINE | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Upper Extremity Deep Vein Thrombosis - blood | Child, Preschool | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Upper Extremity Deep Vein Thrombosis - prevention & control | Hemorrhage - prevention & control | Secondary Prevention | Heparin - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Cardiac Catheterization | Vitamin K - antagonists & inhibitors | Societies, Medical | Platelet Aggregation Inhibitors - administration & dosage | Renal Veins | Thrombosis - blood | Thrombosis - prevention & control | Child | Infant, Newborn | Platelet Aggregation Inhibitors - adverse effects | Upper Extremity Deep Vein Thrombosis - drug therapy | Drug Administration Schedule | Risk Factors | Cooperative Behavior | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Interdisciplinary Communication | Thrombosis - etiology | Blood Coagulation Tests | Fibrinolytic Agents - administration & dosage | Thrombosis - drug therapy | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Cancer Science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1013 - 1017
The RCC ‐ SELECT study showed the correlation between single nucleotide polymorphisms ( SNP ) in STAT 3 gene and survival in metastatic renal cell carcinoma (... 
overall survival | renal cell carcinoma | prognostic factors | interferon‐α | The Era of molecular targeted therapy | Interferon-α | Overall survival | Renal cell carcinoma | Prognostic factors | interferon-α | SURVIVAL | STAT3 POLYMORPHISM | FOLLOW-UP | SORAFENIB | PHASE-III TRIAL | RADICAL NEPHRECTOMY | HYPERCALCEMIA | INVASION | ONCOLOGY | SUNITINIB | interferon-alpha | JAPANESE PATIENTS | Kidney Neoplasms - genetics | Prognosis | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Case-Control Studies | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Carcinoma, Renal Cell - drug therapy | STAT3 Transcription Factor - genetics | Carcinoma, Renal Cell - pathology | Interferon-alpha - therapeutic use | Survival Rate | Treatment Outcome | Interferon-alpha - administration & dosage | Polymorphism, Single Nucleotide - genetics | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Cohort Studies | Thrombocytopenia | Demography | Cell survival | Disease | Cytokines | Research funding | Stat3 protein | Histology | Single-nucleotide polymorphism | Metastasis | Multivariate analysis | Patients | Lymph nodes | Metastases | Hypercalcemia | Studies | Medical prognosis | Kidney cancer | Growth patterns | Interferon | Clear cell-type renal cell carcinoma | Original
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 22, pp. 2154 - 2164
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 426 - 435
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 9, pp. 787 - 798
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 03/2017, Volume 69, Issue 3, pp. 668 - 675
Journal Article